Gilead exercises option for Assembly Bio's herpes treatment programs Dec 22, 2025 08:02AM
Assembly Biosciences (ASMB) PT Raised to $62 at Jefferies Dec 10, 2025 04:53AM
Assembly Biosciences (ASMB) PT Raised to $40 at Mizuho Nov 19, 2025 04:13PM
Assembly Biosciences (ASMB) Misses Q3 EPS by 72c Nov 10, 2025 05:46PM
Assembly Biosciences (ASMB) files for 6.98M share offering by selling stockholders Oct 14, 2025 04:22PM


Oct 14, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Assembly Biosciences (ASMB)
Sep 24, 2025 02:31AM Citizens JMP Starts Assembly Biosciences (ASMB) at Market Outperform
Sep 8, 2025 07:23AM Assembly Biosciences (ASMB) PT Raised to $39 at Guggenheim
Aug 18, 2025 06:38AM H.C. Wainwright Assumes Assembly Biosciences (ASMB) at Buy
Aug 8, 2025 08:05AM Assembly Biosciences prices $175 million equity financing with Gilead
Aug 6, 2025 06:19PM Assembly Biosciences (ASMB) Misses Q2 EPS by 133c
Aug 6, 2025 04:07PM Assembly Biosciences reports interim data for hepatitis delta drug trial
Jun 25, 2025 08:01AM Assembly Biosciences (ASMB) Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B
Mar 25, 2025 06:10AM Guggenheim Starts Assembly Biosciences (ASMB) at Buy
Feb 26, 2025 08:03AM Assembly Biosciences (ASMB) Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
Feb 20, 2025 08:03AM Assembly Biosciences (ASMB) Reports Positive Interim Phase 1a Results from Trial of ABI-1179
Dec 27, 2024 06:56AM H.C. Wainwright Reiterates Neutral Rating on Assembly Biosciences (ASMB)
Dec 26, 2024 08:00AM Assembly Biosciences (ASMB) Reports Interim Phase 1b Results from Clinical Trial of ABI-4334
Dec 19, 2024 08:01AM Assembly Biosciences (ASMB) Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
Nov 8, 2024 06:32AM Assembly Biosciences (ASMB) Misses Q3 EPS by 151c
Sep 24, 2024 06:51AM H.C. Wainwright Reiterates Neutral Rating on Assembly Biosciences (ASMB)
Sep 24, 2024 06:41AM Mizuho Reiterates Outperform Rating on Assembly Biosciences (ASMB)
Sep 23, 2024 08:11AM Assembly Biosciences (ASMB) Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
Sep 20, 2024 03:30AM Jefferies Upgrades Assembly Biosciences (ASMB) to Buy
Aug 8, 2024 06:35PM Assembly Biosciences (ASMB) Misses Q2 EPS by 198c
Jun 17, 2024 08:04AM Assembly Biosciences (ASMB) Announces $12.6M in Equity Financings